查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1589726

栓塞治療市場：按產品、適應症、程序和最終用戶 - 2025-2030 年全球預測

Embolotherapy Market by Product (Embolic Agents, Support Devices), Disease Indication (Cancer, Gastrointestinal Disorders, Neurological Diseases), Procedure, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年栓塞治療市值為44億美元，預計2024年將達47.9億美元，預計複合年成長率為8.91%，到2030年將達到80億美元。

栓塞療法是一種有意阻塞血管以治療腫瘤、動脈瘤和血管畸形等多種疾病的介入療法。栓塞治療的應用涵蓋腫瘤學、婦科和循環系統等領域，解決了傳統手術可能帶來高風險的情況。栓塞治療需要微創、縮短恢復時間並精確針對特定治療區域，這對於不適合手術的患者來說至關重要。使用中，栓塞療法用於治療子宮肌瘤、消化道出血、肝癌和其他血管疾病。最終使用範圍主要是醫院、專科診所和門診手術中心。根據市場洞察，栓塞治療市場的成長是由慢性病盛行率上升、人口老化以及影像和導管技術的持續進步所推動的。最新的商機在於生物相容性和藥物釋放型微球的使用，它可以提高治療效果，同時減少副作用。企業也應探索與學術機構的研發合作，開發栓塞劑新材料。儘管這個市場前景廣闊，但它面臨著挑戰​​，例如嚴格的監管要求、栓塞手術的潛在併發症以及與先進技術相關的高成本。創新可以用於利用人工智慧和機器學習制定個人化治療計劃，以確保患者獲得最佳結果。此外，在醫療基礎設施不斷發展的新興市場擴大這些治療方法的採用，為業務成長提供了一條可行的道路。栓塞治療市場的特點是技術快速進步和競爭加劇，各公司競相提供更安全、更有效的解決方案。因此，該領域的參與者必須策略性地投資於尖端研究和以患者為中心的創新，以保持競爭力並利用新機會。

主要市場統計
基準年[2023] 44億美元
預測年份 [2024] 47.9億美元
預測年份 [2030] 80億美元
複合年成長率（%） 8.91%

市場動態：揭示快速發展的栓塞治療市場的關鍵市場洞察

供需的動態交互作用正在改變栓塞治療市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 目標患者數量增加
    • 政府和民間組織的投資金籌措
    • 微創手術的有利報銷方案
  • 市場限制因素
    • 缺乏足夠的證據和不利的監管情況
  • 市場機會
    • 新興市場的成長機會
    • 擴大栓塞裝置的用途
  • 市場挑戰
    • 缺乏熟練的外科醫生
    • 在新興國家獲得栓塞治療的高成本且隨之而來的困難

波特的五力：駕馭栓塞治療市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解栓塞治療市場的外部影響

外部宏觀環境因素在塑造栓塞治療市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解栓塞治療市場的競爭格局

栓塞治療市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來發現自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣栓塞治療市場供應商的績效評估

FPNV定位矩陣是評估栓塞治療市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了栓塞治療市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，對栓塞治療市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 目標患者數量增加
      • 政府和私人組織的投資和資助
      • 微創手術的有利報銷方案
    • 抑制因素
      • 缺乏足夠的證據和不利的監管情況
    • 機會
      • 新興市場的成長機會
      • 擴大栓塞裝置的用途
    • 任務
      • 缺乏熟練的外科醫生
      • 栓塞手術在新興國家昂貴且難以實施。
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章栓塞治療市場：依產品

  • 栓塞劑
    • 可拆卸氣球
    • 栓塞彈簧圈
    • 栓塞系統
    • 液態栓塞劑
    • 微球
  • 支撐裝置
    • 導管導引線
    • 微導管

第7章栓塞治療市場：按疾病適應症

  • 癌症
  • 胃腸道疾病
  • 神經系統疾病
  • 周圍血管疾病
  • 泌尿系統和腎臟疾病

第8章按程序分類的栓塞治療市場

  • 經動脈化療栓塞術
  • 經導管動脈栓塞術
  • 經導管動脈栓塞及選擇性體內放射療法

第9章栓塞治療市場：依最終使用者分類

  • 門診手術中心
  • 醫院/診所

第10章美洲栓塞治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章：亞太地區栓塞治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲栓塞治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Acandis GmbH
  • Balt Extrusion
  • Boston Scientific Corporation
  • Cook Medical Incorporated
  • Guerbet
  • Johnson & Johnson Services, Inc.
  • Kaneka Corporation
  • Medtronic PLC
  • Meril Life Sciences Pvt., Ltd.
  • Merit Medical Systems Inc.
  • Penumbra, Inc.
  • Sirtex Medical Limited
  • Stryker Corporation
  • Terumo Corporation
Product Code: MRR-4308E1C8878D

The Embolotherapy Market was valued at USD 4.40 billion in 2023, expected to reach USD 4.79 billion in 2024, and is projected to grow at a CAGR of 8.91%, to USD 8.00 billion by 2030.

Embolotherapy is an interventional therapy that deliberately blocks blood vessels to treat various medical conditions, such as tumors, aneurysms, or vascular malformations. The scope of embolotherapy extends across fields like oncology, gynecology, and cardiology, addressing conditions where traditional surgery might pose high risks. The necessity of embolotherapy lies in its minimally invasive nature, reduced recovery times, and precision in targeting specific treatment areas, making it indispensable for patients who are not candidates for surgical interventions. In terms of application, embolotherapy is utilized in treating uterine fibroids, gastrointestinal bleeding, liver cancer, and several other vascular conditions. The end-use scope primarily covers hospitals, specialist clinics, and ambulatory surgical centers. Market insights reveal that the growth of the embolotherapy market is driven by the rising prevalence of chronic diseases, the aging population, and continuous advancements in imaging and catheter technologies. The latest opportunities lie in the adoption of biocompatible and drug-eluting microspheres, which could enhance treatment efficacy while reducing side effects. Companies should also explore collaborations with academic institutions for R&D to develop novel materials for embolic agents. While the market is promising, it faces challenges such as strict regulatory requirements, potential complications from embolization procedures, and high costs associated with advanced technologies. Innovation can be channeled into developing individualized treatment plans using AI and machine learning, ensuring the best outcomes for patients. Furthermore, expanding the adoption of these therapies in emerging markets, where healthcare infrastructure is evolving, presents a viable pathway for business growth. The embolotherapy market is characterized by rapid technological progress and heightened competition, with firms vying to deliver safer, more effective solutions. Consequently, players in this space must strategically invest in advanced research and patient-centric innovations to sustain their competitive edge and capitalize on emerging opportunities.

KEY MARKET STATISTICS
Base Year [2023] USD 4.40 billion
Estimated Year [2024] USD 4.79 billion
Forecast Year [2030] USD 8.00 billion
CAGR (%) 8.91%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Embolotherapy Market

The Embolotherapy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing target patient population
    • Investment & funding by government and private organizations
    • Favorable reimbursement scenario for minimally invasive surgeries
  • Market Restraints
    • Lack of sufficient evidence & unfavorable regulatory scenario
  • Market Opportunities
    • Growth opportunities in emerging markets
    • Expanding applications of embolization devices
  • Market Challenges
    • Lack of skilled surgeons
    • High cost and resulting difficulties in accessing embolization in developing countries

Porter's Five Forces: A Strategic Tool for Navigating the Embolotherapy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Embolotherapy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Embolotherapy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Embolotherapy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Embolotherapy Market

A detailed market share analysis in the Embolotherapy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Embolotherapy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Embolotherapy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Embolotherapy Market

A strategic analysis of the Embolotherapy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Embolotherapy Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acandis GmbH, Balt Extrusion, Boston Scientific Corporation, Cook Medical Incorporated, Guerbet, Johnson & Johnson Services, Inc., Kaneka Corporation, Medtronic PLC, Meril Life Sciences Pvt., Ltd., Merit Medical Systems Inc., Penumbra, Inc., Sirtex Medical Limited, Stryker Corporation, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Embolotherapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Embolic Agents and Support Devices. The Embolic Agents is further studied across Detachable Balloons, Embolic Coils, Embolic Plug Systems, Liquid Embolic Agents, and Microspheres. The Support Devices is further studied across Guidewires and Microcatheters.
  • Based on Disease Indication, market is studied across Cancer, Gastrointestinal Disorders, Neurological Diseases, Peripheral Vascular Disease, and Urological & Nephrological Disorders.
  • Based on Procedure, market is studied across Transarterial Chemoembolization, Transcatheter Arterial Embolization, and Transcatheter Arterial Radioembolization & Selective Internal Radiation Therapy.
  • Based on End-User, market is studied across Ambulatory Surgery Centers and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing target patient population
      • 5.1.1.2. Investment & funding by government and private organizations
      • 5.1.1.3. Favorable reimbursement scenario for minimally invasive surgeries
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of sufficient evidence & unfavorable regulatory scenario
    • 5.1.3. Opportunities
      • 5.1.3.1. Growth opportunities in emerging markets
      • 5.1.3.2. Expanding applications of embolization devices
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skilled surgeons
      • 5.1.4.2. High cost and resulting difficulties in accessing embolization in developing countries
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Embolotherapy Market, by Product

  • 6.1. Introduction
  • 6.2. Embolic Agents
    • 6.2.1. Detachable Balloons
    • 6.2.2. Embolic Coils
    • 6.2.3. Embolic Plug Systems
    • 6.2.4. Liquid Embolic Agents
    • 6.2.5. Microspheres
  • 6.3. Support Devices
    • 6.3.1. Guidewires
    • 6.3.2. Microcatheters

7. Embolotherapy Market, by Disease Indication

  • 7.1. Introduction
  • 7.2. Cancer
  • 7.3. Gastrointestinal Disorders
  • 7.4. Neurological Diseases
  • 7.5. Peripheral Vascular Disease
  • 7.6. Urological & Nephrological Disorders

8. Embolotherapy Market, by Procedure

  • 8.1. Introduction
  • 8.2. Transarterial Chemoembolization
  • 8.3. Transcatheter Arterial Embolization
  • 8.4. Transcatheter Arterial Radioembolization & Selective Internal Radiation Therapy

9. Embolotherapy Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgery Centers
  • 9.3. Hospitals & Clinics

10. Americas Embolotherapy Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Embolotherapy Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Embolotherapy Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Acandis GmbH
  • 3. Balt Extrusion
  • 4. Boston Scientific Corporation
  • 5. Cook Medical Incorporated
  • 6. Guerbet
  • 7. Johnson & Johnson Services, Inc.
  • 8. Kaneka Corporation
  • 9. Medtronic PLC
  • 10. Meril Life Sciences Pvt., Ltd.
  • 11. Merit Medical Systems Inc.
  • 12. Penumbra, Inc.
  • 13. Sirtex Medical Limited
  • 14. Stryker Corporation
  • 15. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. EMBOLOTHERAPY MARKET RESEARCH PROCESS
  • FIGURE 2. EMBOLOTHERAPY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EMBOLOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EMBOLOTHERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. EMBOLOTHERAPY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EMBOLOTHERAPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EMBOLOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. EMBOLOTHERAPY MARKET DYNAMICS
  • TABLE 7. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY DETACHABLE BALLOONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC COILS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC PLUG SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY MICROSPHERES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY MICROCATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY NEUROLOGICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY UROLOGICAL & NEPHROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TRANSARTERIAL CHEMOEMBOLIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TRANSCATHETER ARTERIAL EMBOLIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TRANSCATHETER ARTERIAL RADIOEMBOLIZATION & SELECTIVE INTERNAL RADIATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 282. EMBOLOTHERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 283. EMBOLOTHERAPY MARKET, FPNV POSITIONING MATRIX, 2023